johnson & johnson cfo joseph wolk on q3 results: very well-positioned into 2024 and beyond
Published 10 months ago • 3.4K plays • Length 6:08Download video MP4
Download video MP3
Similar videos
-
0:53
johnson & johnson cfo on drug pricing
-
4:16
j&j cfo joseph wolk on q4 earnings beat: near- and long-term looks very strong at the company
-
8:41
j&j cfo joseph wolk on q2 earnings beat: very pleased with the performance overall
-
3:50
j&j cfo joseph wolk on q1 earnings
-
5:11
johnson & johnson cfo joseph wolk on q4 earnings beat
-
5:00
'i'm not trying to trick you': ro khanna presses johnson & johnson lawyer about drug prices
-
9:54
jo johnson
-
5:02
j&j ceo breaks down the plan to split into two public companies
-
6:12
watch cnbc's full interview with johnson & johnson cfo joseph wolk
-
5:32
johnson & johnson cfo on q3 earnings, covid vaccine booster
-
6:10
drug pipeline is well positioned for 2024, says j&j cfo
-
2:37
johnson & johnson cfo on third-quarter earnings results
-
6:07
j&j cfo joseph wolk on q2 earnings beat: we're in a very strong position for second half of 2023
-
4:37
johnson & johnson cfo joseph wolk on covid-19 study pause
-
4:13
johnson & johnson cfo joseph wolk on supply challenges of tylenol, motrin
-
3:53
j&j's q1 earnings miss was because of covid-19 vaccine: cfo joseph wolk
-
3:48
great scientific innovation continues to produce great financial results for our company: j&j cfo
-
4:53
johnson & johnson cfo on q2 earnings, raising guidance, covid-19 and more
-
3:41
johnson & johnson cfo breaks down mixed earnings report, full-year guidance
-
6:01
j&j cfo on third-quarter, outlook, consumer spinoff
-
9:42
johnson & johnson cfo on q2 earnings, litigation, product pipeline
-
1:39
johnson & johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge